ARCHIVES

FDA Forms Office of Combination Products;

This article is from The Cancer Letter archive.

Vol. 29 No. 02 | January 10, 2003

Download PDF Visit The Full Archive

Related Articles

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

ACS Did Not Sign Bumpers Letter

May 1, 1992

Five Center Core Grants Renewed

February 2, 1979

NCI By Pass Budget For FY 1987 Is $1.57 Bil.

October 18, 1985

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

October 11, 1996

In Brief: Baltimore Resigns as Rockefeller President; Perry Named Medical Director At Ellis Fischel

December 13, 1991